A total of 25.2% of patients had lesions suspicious for PC recurrence with PSMA-PET/CT with a total of 44 lesions, including 11 putative local recurrences, 22 putative lymph node metastases, and 11 putative bone metastases. This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.